125 related articles for article (PubMed ID: 38196144)
1. Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism.
Ren J; Zhao C; Sun R; Sun J; Lu L; Wu J; Li S; Cui L
Int J Cancer; 2024 May; 154(9):1626-1638. PubMed ID: 38196144
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
3. ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.
Roundhill EA; Jabri S; Burchill SA
Cancer Lett; 2019 Jul; 453():142-157. PubMed ID: 30910588
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix induces doxorubicin-resistance in human osteosarcoma cells by suppression of p53 function.
Harisi R; Dudas J; Nagy-Olah J; Timar F; Szendroi M; Jeney A
Cancer Biol Ther; 2007 Aug; 6(8):1240-6. PubMed ID: 17703109
[TBL] [Abstract][Full Text] [Related]
5. Establishment of new multidrug-resistant human osteosarcoma cell lines.
Oda Y; Matsumoto Y; Harimaya K; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2000; 7(4):859-66. PubMed ID: 10854558
[TBL] [Abstract][Full Text] [Related]
6. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
7. Osteomimetic matrix components alter cell migration and drug response in a 3D tumour-engineered osteosarcoma model.
Pavlou M; Shah M; Gikas P; Briggs T; Roberts SJ; Cheema U
Acta Biomater; 2019 Sep; 96():247-257. PubMed ID: 31302294
[TBL] [Abstract][Full Text] [Related]
8. Cinobufagin inhibits tumor progression and reduces doxorubicin resistance by enhancing FOXO1-mediated transcription of FCGBP in osteosarcoma.
Ma X; Suo Z; Ma X; Zhan C; Luo G; Song J
J Ethnopharmacol; 2022 Oct; 296():115433. PubMed ID: 35690338
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA
Lee AM; Ferdjallah A; Moore E; Kim DC; Nath A; Greengard E; Huang RS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681828
[TBL] [Abstract][Full Text] [Related]
10. Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models.
Gallego B; Murillo D; Rey V; Huergo C; Estupiñán Ó; Rodríguez A; Tornín J; Rodríguez R
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742867
[TBL] [Abstract][Full Text] [Related]
11. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein.
Si M; Zhao J; Li X; Tian JG; Li YG; Li JM
Chin Med J (Engl); 2013 Nov; 126(21):4116-23. PubMed ID: 24229684
[TBL] [Abstract][Full Text] [Related]
12. Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS.
Ucci A; Cappariello A; Ponzetti M; Tennant F; Loftus AEP; Shefferd K; Maurizi A; Delle Monache S; Teti A; Rucci N
Bone; 2021 Dec; 153():116130. PubMed ID: 34329816
[TBL] [Abstract][Full Text] [Related]
13. Bupivacaine and Lidocaine Induce Apoptosis in Osteosarcoma Tumor Cells.
Mirshahidi S; Shields TG; de Necochea-Campion R; Yuan X; Janjua A; Williams NL; Mirshahidi HR; Reeves ME; Duerksen-Hughes P; Zuckerman LM
Clin Orthop Relat Res; 2021 Jan; 479(1):180-194. PubMed ID: 33009230
[TBL] [Abstract][Full Text] [Related]
14. Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway.
Yuan B; Shi K; Zha J; Cai Y; Gu Y; Huang K; Yue W; Zhai Q; Ding N; Ren W; He W; Xu Y; Wang T
Cell Death Dis; 2023 Jan; 14(1):51. PubMed ID: 36681687
[TBL] [Abstract][Full Text] [Related]
15. Superenhancers activate the autophagy-related genes Beclin1 and LC3B to drive metastasis and drug resistance in osteosarcoma.
Wang H; Liu Z; Wang J; Hu F; Zhou Q; Wei L; Bao Q; Wang J; Liang J; Liu Z; Zhang W
Front Med; 2022 Dec; 16(6):883-895. PubMed ID: 36334211
[TBL] [Abstract][Full Text] [Related]
16. Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment.
Rong ZJ; Yang LJ; Cai BT; Zhu LX; Cao YL; Wu GF; Zhang ZJ
J Mater Sci Mater Med; 2016 May; 27(5):89. PubMed ID: 26975746
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
Zhang Y; Duan G; Feng S
Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
[TBL] [Abstract][Full Text] [Related]
19. GEM-Based Metabolic Profiling for Human Bone Osteosarcoma under Different Glucose and Glutamine Availability.
Weglarz-Tomczak E; Rijlaarsdam DJ; Tomczak JM; Brul S
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540580
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human multicentric osteosarcoma using newly established cells derived from multicentric osteosarcoma.
Yamamoto Y; Yamamoto N; Tajima K; Ohno A; Washimi Y; Ishimura D; Washimi O; Yamada H
J Cancer Res Clin Oncol; 2011 Mar; 137(3):423-33. PubMed ID: 20440512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
